Multi-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells-Reference-Cited by-同舟云学术

Multi-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells

Published:2024-08-13 Issue: Volume: Page:
ISSN:1755-4330
Container-title:Nature Chemistry
language:en
Short-container-title:Nat. Chem.

Author:

Njomen Evert^ORCID,Hayward Rachel E.^ORCID,DeMeester Kristen E.,Ogasawara Daisuke^ORCID,Dix Melissa M.,Nguyen Tracey,Ashby Paige,Simon Gabriel M.,Schreiber Stuart L.,Melillo Bruno^ORCID,Cravatt Benjamin F.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Cancer Research UK

Howard Hughes Medical Institute

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41557-024-01601-1.pdf

Reference81 articles.

1. Chakravarty, D. & Solit, D. B. Clinical cancer genomic profiling. Nat. Rev. Genet. 22, 483–501 (2021).

2. Schreiber, S. L. A chemical biology view of bioactive small molecules and a binder-based approach to connect biology to precision medicines. Isr. J. Chem. 59, 52–59 (2019).

3. Wang, Z. Z., Shi, X. X., Huang, G. Y., Hao, G. F. & Yang, G. F. Fragment-based drug discovery supports drugging ‘undruggable’ protein-protein interactions. Trends Biochem. Sci. 48, 539–552 (2023).

4. St Denis, J. D., Hall, R. J., Murray, C. W., Heightman, T. D. & Rees, D. C. Fragment-based drug discovery: opportunities for organic synthesis. RSC Med. Chem. 12, 321–329 (2020).

5. Lundquist, K. P., Panchal, V., Gotfredsen, C. H., Brenk, R. & Clausen, M. H. Fragment-based drug discovery for RNA targets. ChemMedChem 16, 2588–2603 (2021).